Method for separating nitrogen out of a hydrocarbon-rich fraction that contains nitrogen

Details for Australian Patent Application No. 2002319155 (hide)

Owner Statoil ASA Linde Aktiengesellschaft

Inventors Butz, Peter; Jensen, Rune; Gwinner, Martin; Paurola, Pentti; Stockmann, Rudolf

Agent Davies Collison Cave

Pub. Number AU-B-2002319155

PCT Number PCT/EP02/04721

PCT Pub. Number WO2002/088612

Priority 101 21 339.5 02.05.01 DE

Filing date 29 April 2002

Wipo publication date 11 November 2002

Acceptance publication date 29 March 2007

International Classifications

F25J 3/02 (2006.01) Processes or apparatus for separating the constituents of gaseous mixtures involving the use of liquefaction or solidification - by rectification, i.e. by continuous interchange of heat and material between a vapour stream and a liquid stream

F25J 1/02 (2006.01) Processes or apparatus for liquefying or solidifying gases or gaseous mixtures

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 101 21 339.5 02.05.01 DE

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002319155

29 March 2007 Application Accepted

  Published as AU-B-2002319155

2 August 2007 Standard Patent Sealed

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002319156-PHARMACEUTICAL COMPOSITION WHICH REDUCES OR ELIMINATES DRUG ABUSE POTENTIAL

2002319154-Pharmaceutical dosage form of amorphous nelfinavir mesylate